FLT3-ITD knockin impairs hematopoietic stem cell quiescence/homeostasis, leading to myeloproliferative neoplasm

Cell Stem Cell. 2012 Sep 7;11(3):346-58. doi: 10.1016/j.stem.2012.05.027.

Abstract

Internal tandem duplication (ITD) mutations within the FMS-like tyrosine kinase-3 (FLT3) render the receptor constitutively active driving proliferation and survival in leukemic blasts. Expression of FLT3-ITD from the endogenous promoter in a murine knockin model results in progenitor expansion and a myeloproliferative neoplasm. In this study, we show that this expansion begins with overproliferation within a compartment of normally quiescent long-term hematopoietic stem cells (LT-HSCs), which become rapidly depleted. This depletion is reversible upon treatment with the small molecule inhibitor Sorafenib, which also ablates the disease. Although the normal LT-HSC has been defined as FLT3(-) by flow cytometric detection, we demonstrate that FLT3 is capable of playing a role within this compartment by examining the effects of constitutively activated FLT3-ITD. This indicates an important link between stem cell quiescence/homeostasis and myeloproliferative disease while also giving novel insight into the emergence of FLT3-ITD mutations in the evolution of leukemic transformation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bone Marrow / drug effects
  • Bone Marrow / metabolism
  • Bone Marrow / pathology
  • Bone Marrow Neoplasms / genetics
  • Bone Marrow Neoplasms / pathology*
  • Cell Compartmentation / drug effects
  • Cell Cycle / drug effects
  • Cell Proliferation / drug effects
  • Enzyme Activation / drug effects
  • Female
  • Gene Duplication* / drug effects
  • Gene Expression Regulation, Neoplastic / drug effects
  • Gene Knock-In Techniques*
  • Hematopoietic Stem Cell Transplantation
  • Hematopoietic Stem Cells / drug effects
  • Hematopoietic Stem Cells / metabolism
  • Hematopoietic Stem Cells / pathology*
  • Homeostasis* / drug effects
  • Homeostasis* / genetics
  • Male
  • Mice
  • Neoplastic Stem Cells / drug effects
  • Neoplastic Stem Cells / metabolism
  • Neoplastic Stem Cells / pathology
  • Niacinamide / analogs & derivatives
  • Niacinamide / pharmacology
  • Phenotype
  • Phenylurea Compounds / pharmacology
  • Promoter Regions, Genetic / genetics
  • RNA, Messenger / genetics
  • RNA, Messenger / metabolism
  • Side-Population Cells / drug effects
  • Side-Population Cells / metabolism
  • Side-Population Cells / pathology
  • Signal Transduction / drug effects
  • Small Molecule Libraries / pharmacology
  • Sorafenib
  • Tandem Repeat Sequences / genetics*
  • fms-Like Tyrosine Kinase 3 / genetics*
  • fms-Like Tyrosine Kinase 3 / metabolism

Substances

  • Phenylurea Compounds
  • RNA, Messenger
  • Small Molecule Libraries
  • Niacinamide
  • Sorafenib
  • Flt3 protein, mouse
  • fms-Like Tyrosine Kinase 3